HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Koji Oba Selected Research

Pathologic Constriction (Stenosis)

9/2019Impact of Residual Stenosis on the Angiographic Edge Restenosis of a Second-Generation Drug-Eluting Stent.
1/2014Cardiac magnetic resonance performs better in the detection of functionally significant coronary artery stenosis compared to single-photon emission computed tomography and dobutamine stress echocardiography.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Koji Oba Research Topics

Disease

41Colorectal Neoplasms (Colorectal Cancer)
07/2023 - 04/2006
25Stomach Neoplasms (Stomach Cancer)
12/2023 - 01/2006
21Neoplasms (Cancer)
04/2022 - 06/2007
14Neoplasm Metastasis (Metastasis)
05/2023 - 07/2009
12Rectal Neoplasms (Rectal Cancer)
11/2023 - 02/2015
9Colonic Neoplasms (Colon Cancer)
06/2023 - 07/2015
8Systemic Scleroderma (Systemic Sclerosis)
11/2022 - 01/2019
7BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2023 - 01/2014
6Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 01/2015
5Type 2 Diabetes Mellitus (MODY)
11/2023 - 01/2015
5Lymphatic Metastasis
04/2022 - 07/2009
5Heart Failure
10/2020 - 10/2013
5Diarrhea
07/2020 - 01/2006
4Sclerosis
11/2022 - 11/2020
4Neutropenia
12/2020 - 01/2014
4Nausea
12/2019 - 01/2012
4Hypertension (High Blood Pressure)
01/2018 - 08/2008
3Anemia
03/2024 - 09/2012
3Rheumatoid Arthritis
11/2021 - 12/2017
3VLCAD deficiency
02/2021 - 06/2018
3Fatigue
02/2021 - 11/2009
3Obesity
10/2020 - 06/2010
3Diabetes Mellitus
06/2020 - 01/2013
3Hemorrhage
05/2020 - 06/2014
3Vomiting
12/2019 - 01/2012
3Pneumonia (Pneumonitis)
01/2017 - 11/2009
3Renal Cell Carcinoma (Grawitz Tumor)
05/2015 - 01/2013
2Urinary Bladder Neoplasms (Bladder Cancer)
08/2023 - 01/2013
2Renal Insufficiency (Renal Failure)
07/2023 - 01/2017
2Rheumatic Diseases (Rheumatism)
08/2022 - 07/2021
2Adenocarcinoma
04/2022 - 11/2009
2Disease Progression
01/2022 - 03/2013
2Myalgia
02/2021 - 06/2018
2Fibrosis (Cirrhosis)
11/2020 - 12/2019
2Pathologic Constriction (Stenosis)
09/2019 - 01/2014
2Rare Diseases (Rare Disease)
09/2019 - 06/2018
2Human Influenza (Influenza)
06/2018 - 03/2014
2Hyperglycemia
01/2016 - 01/2015
2Atherosclerosis
01/2016 - 01/2015
2Polymyositis
08/2015 - 01/2015
2Dermatomyositis (Dermatopolymyositis)
08/2015 - 01/2015

Drug/Important Bio-Agent (IBA)

17Oxaliplatin (Eloxatin)FDA LinkGeneric
07/2023 - 02/2012
13Fluorouracil (Carac)FDA LinkGeneric
06/2023 - 01/2007
9Irinotecan (Camptosar)FDA LinkGeneric
05/2023 - 12/2013
8Leucovorin (Folinic Acid)FDA Link
06/2023 - 12/2013
8Biomarkers (Surrogate Marker)IBA
04/2022 - 11/2013
8Paclitaxel (Taxol)FDA LinkGeneric
11/2021 - 01/2006
8Bevacizumab (Avastin)FDA Link
12/2020 - 01/2011
7Capecitabine (Xeloda)FDA Link
06/2023 - 03/2013
7Cetuximab (Erbitux)FDA Link
11/2019 - 04/2014
7candesartanIBA
01/2018 - 02/2008
7XELOXIBA
01/2017 - 01/2011
6Panitumumab (Vectibix)FDA Link
12/2022 - 01/2015
6Dasatinib (BMS 354825)FDA Link
03/2020 - 01/2014
6Antihypertensive Agents (Antihypertensives)IBA
01/2018 - 02/2008
5TegafurIBA
05/2023 - 04/2009
5Rituximab (Mabthera)FDA Link
11/2022 - 07/2020
4UracilIBA
05/2023 - 07/2014
4Amlodipine (Norvasc)FDA LinkGeneric
01/2018 - 02/2008
3Tyrosine Kinase InhibitorsIBA
05/2023 - 01/2018
3Infliximab (Remicade)FDA Link
11/2021 - 12/2017
3Fatty Acids (Saturated Fatty Acids)IBA
02/2021 - 06/2018
3BezafibrateIBA
02/2021 - 06/2018
3Carcinoembryonic AntigenIBA
05/2018 - 05/2013
3polysaccharide-KIBA
01/2018 - 04/2006
3Imatinib Mesylate (Gleevec)FDA Link
12/2015 - 01/2014
3Cisplatin (Platino)FDA LinkGeneric
05/2013 - 01/2007
2Hemoglobins (Hemoglobin)IBA
03/2024 - 10/2013
2Trinitrotoluene (TNT)IBA
11/2023 - 05/2023
2Circulating Tumor DNAIBA
04/2022 - 02/2019
2Indicators and Reagents (Reagents)IBA
01/2022 - 10/2020
2ErbB Receptors (EGF Receptor)IBA
07/2021 - 11/2019
2trifluridine tipiracil drug combinationIBA
07/2021 - 12/2020
2Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
11/2020 - 07/2020
2Dexamethasone (Maxidex)FDA LinkGeneric
12/2019 - 07/2015
2Palonosetron (Aloxi)FDA Link
12/2019 - 07/2015
2EnzymesIBA
09/2019 - 06/2018
2Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA
09/2019 - 06/2018
2Long-Chain Acyl-CoA Dehydrogenase (Long-Chain-Acyl-Coenzyme A Dehydrogenase)IBA
09/2019 - 06/2018
2laninamivirIBA
06/2018 - 03/2014
2Neuraminidase (Sialidase)IBA
06/2018 - 03/2014
2Zanamivir (Relenza)FDA Link
06/2018 - 03/2014
2LigandsIBA
01/2018 - 01/2015
2Monoclonal AntibodiesIBA
01/2017 - 12/2016
2Therapeutic UsesIBA
01/2017 - 03/2011
2MacrolidesIBA
01/2017 - 05/2016
2Tacrolimus (Prograf)FDA LinkGeneric
08/2015 - 01/2015

Therapy/Procedure

27Drug Therapy (Chemotherapy)
12/2023 - 01/2006
24Therapeutics
12/2022 - 11/2009
13Adjuvant Chemotherapy
07/2023 - 01/2006
8Neoadjuvant Therapy
11/2023 - 05/2013
5Chemoradiotherapy
05/2023 - 02/2015
4Lymph Node Excision (Lymph Node Dissection)
04/2022 - 07/2018
3Radiotherapy
10/2020 - 11/2013
3Gastrectomy
03/2018 - 06/2014
2Drug Tapering
07/2023 - 12/2020
2Duration of Therapy
07/2023 - 05/2023
2Combination Drug Therapy (Combination Chemotherapy)
01/2018 - 12/2013
2Secondary Prevention
06/2016 - 01/2011
2Catheters
10/2015 - 03/2015